Bispecific antibodies

The concept of using bispecific antibodies for cancer therapy by retargeting immune effector cells was developed more than 25 years ago. However, initial clinical studies were rather disappointing mainly due to low efficacy, severe side effects and the immunogenicity of the bispecific antibodies. A...

Descrición completa

Detalles Bibliográficos
Publicado en:Springer ebooks.
Autor Corporativo: SpringerLink (Online service)
Outros autores: Kontermann, Roland 1961- (Editor)
Formato: Electronic Resource
Idioma:English
Publicado: Berlin, Heidelberg Springer Berlin Heidelberg c2011
Subjects:
Acceso en liña:Available for University of the Philippines Diliman via SpringerLink. Click here to access